CID 151171

Conivaptan

Structural Information

Molecular Formula
C32H26N4O2
SMILES
CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6
InChI
InChI=1S/C32H26N4O2/c1-21-33-28-19-20-36(29-14-8-7-13-27(29)30(28)34-21)32(38)23-15-17-24(18-16-23)35-31(37)26-12-6-5-11-25(26)22-9-3-2-4-10-22/h2-18H,19-20H2,1H3,(H,33,34)(H,35,37)
InChIKey
IKENVDNFQMCRTR-UHFFFAOYSA-N
Compound name
N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

237
References

4667
Patents

498.20557 Da
Monoisotopic Mass

5.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 499.21285 226.7
[M+Na]+ 521.19479 231.9
[M-H]- 497.19829 237.0
[M+NH4]+ 516.23939 231.0
[M+K]+ 537.16873 227.4
[M+H-H2O]+ 481.20283 214.8
[M+HCOO]- 543.20377 239.8
[M+CH3COO]- 557.21942 232.1
[M+Na-2H]- 519.18024 225.9
[M]+ 498.20502 221.6
[M]- 498.20612 221.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe